{"id":1141,"date":"2021-02-19T10:02:55","date_gmt":"2021-02-19T15:02:55","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=1141"},"modified":"2024-09-04T13:21:29","modified_gmt":"2024-09-04T17:21:29","slug":"the-aptamer-advantage-breaking-free-from-antibody-uncertainty","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/es\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/","title":{"rendered":"The Aptamer Advantage: Breaking Free from Antibody Uncertainty"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

In the ever-evolving field of diagnostics, precision and predictability are key to developing reliable products. However, the traditional reliance on antibodies poses significant challenges due to the inherent uncertainties in measuring their binding affinity and quantity. This creates a complex, two-variable problem that complicates product development and performance consistency. Enter The Aptamer Advantage<\/strong>\u2014a game-changing approach that addresses these challenges head-on. Aptamers, with their ability to be chemically synthesized and accurately measured, offer a level of control and reliability that antibodies simply cannot match. In this blog, we’ll explore NeoVentures’ cutting-edge aptamer technology. This technology is transforming diagnostic development from a laborious, trial-and-error process into a streamlined, science-driven approach that delivers optimal results.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

The Challenges of Working with Antibodies<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Imagine trying to sell a product without really knowing how much you\u2019re selling. Consider the challenge of explaining to clients that you only know the product’s effectiveness when diluted to a certain level where it stops working. Surprisingly, this is an accepted practice in the antibody business.<\/p>

The reason for this uncertainty lies in the difficulty of measuring the binding affinity of a monoclonal antibody without knowing its exact quantity. Conversely, it\u2019s challenging to determine the quantity of a monoclonal antibody without understanding its binding affinity. This situation creates a two-variable problem with only one equation, leading to inherent challenges in the use of antibodies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

The Aptamer Advantage: Precision and Predictability<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Now, imagine eliminating these problems when developing a new diagnostic device. What if you knew the exact amount of ligand you were using, the binding affinity for the target, and the binding affinities for off-target molecules? Instead of testing countless permutations of capture and detection ligand ratios, you could intelligently predict product performance from the start.<\/p>

This level of precision is achievable with aptamers. Unlike antibodies, aptamers are chemically synthesized, allowing for accurate measurement of concentration using a simple absorbance reading at 260 nm. Knowing the exact amount of aptamer also means knowing its binding affinity to both target and off-target molecules.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

NeoVentures' Cutting-Edge Aptamer Technology<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

At NeoVentures, we\u2019ve developed advanced chemistries that allow us to immobilize aptamers with high yield and precisely measure the immobilized amount. Importantly, our process ensures that aptamers are immobilized in an oriented manner, meaning they are attached by one end of the molecule. This orientation guarantees that all immobilized aptamers are fully functional.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Transforming Diagnostics into a Science-Driven Process<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

By using aptamers, you can transform the development of diagnostic kits from a trial-and-error process into a scientifically driven, plug-and-play approach. This transformation not only saves money during product development but also enables you to create products that consistently perform at their best, ensuring optimal outcomes for your clients.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

For more information check out our website here<\/a>\u00a0<\/strong><\/span>and keep up to date by following us on LinkedIn<\/strong><\/span>.<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

In the ever-evolving field of diagnostics, precision and predictability are key to developing reliable products. However, the traditional reliance on antibodies poses significant challenges due to the inherent uncertainties in measuring their binding affinity and quantity. This creates a complex, two-variable problem that complicates product development and performance consistency. Enter The Aptamer Advantage\u2014a game-changing approach… Leer m\u00e1s »The Aptamer Advantage: Breaking Free from Antibody Uncertainty<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":6085,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8,11,30],"tags":[],"class_list":["post-1141","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers","category-aptamers-in-diagnostics","category-introductory"],"yoast_head":"\nThe Aptamer Advantage: Breaking Free from Antibody Uncertainty<\/title>\n<meta name=\"description\" content=\"Unlock the potential of aptamers & revolutionize your diagnostic device development! Discover the Aptamer Advantage.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/es\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Aptamer Advantage: Breaking Free from Antibody Uncertainty\" \/>\n<meta property=\"og:description\" content=\"Unlock the potential of aptamers & revolutionize your diagnostic device development! Discover the Aptamer Advantage.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/es\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-19T15:02:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-04T17:21:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/02\/The-Aptamer-Advantage-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"930\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"partyinfrance\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"partyinfrance\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/\"},\"author\":{\"name\":\"partyinfrance\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/34934951075d3d931c9216ed7f568fe6\"},\"headline\":\"The Aptamer Advantage: Breaking Free from Antibody Uncertainty\",\"datePublished\":\"2021-02-19T15:02:55+00:00\",\"dateModified\":\"2024-09-04T17:21:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/\"},\"wordCount\":474,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/The-Aptamer-Advantage-1.jpg\",\"articleSection\":[\"Aptamers\",\"Aptamers in Diagnostics\",\"Introductory\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/\",\"name\":\"The Aptamer Advantage: Breaking Free from Antibody Uncertainty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/The-Aptamer-Advantage-1.jpg\",\"datePublished\":\"2021-02-19T15:02:55+00:00\",\"dateModified\":\"2024-09-04T17:21:29+00:00\",\"description\":\"Unlock the potential of aptamers & revolutionize your diagnostic device development! Discover the Aptamer Advantage.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/The-Aptamer-Advantage-1.jpg\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/The-Aptamer-Advantage-1.jpg\",\"width\":930,\"height\":630,\"caption\":\"The Aptamer Advantage: Breaking Free From Antibody Uncertainty\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Aptamer Advantage: Breaking Free from Antibody Uncertainty\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/34934951075d3d931c9216ed7f568fe6\",\"name\":\"partyinfrance\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g\",\"caption\":\"partyinfrance\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Aptamer Advantage: Breaking Free from Antibody Uncertainty","description":"Unlock the potential of aptamers & revolutionize your diagnostic device development! Discover the Aptamer Advantage.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/es\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/","og_locale":"es_ES","og_type":"article","og_title":"The Aptamer Advantage: Breaking Free from Antibody Uncertainty","og_description":"Unlock the potential of aptamers & revolutionize your diagnostic device development! Discover the Aptamer Advantage.","og_url":"https:\/\/neoaptamers.com\/es\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/","og_site_name":"neoaptamers","article_published_time":"2021-02-19T15:02:55+00:00","article_modified_time":"2024-09-04T17:21:29+00:00","og_image":[{"width":930,"height":630,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/02\/The-Aptamer-Advantage-1.jpg","type":"image\/jpeg"}],"author":"partyinfrance","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"partyinfrance","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/"},"author":{"name":"partyinfrance","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/34934951075d3d931c9216ed7f568fe6"},"headline":"The Aptamer Advantage: Breaking Free from Antibody Uncertainty","datePublished":"2021-02-19T15:02:55+00:00","dateModified":"2024-09-04T17:21:29+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/"},"wordCount":474,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/02\/The-Aptamer-Advantage-1.jpg","articleSection":["Aptamers","Aptamers in Diagnostics","Introductory"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/","url":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/","name":"The Aptamer Advantage: Breaking Free from Antibody Uncertainty","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/02\/The-Aptamer-Advantage-1.jpg","datePublished":"2021-02-19T15:02:55+00:00","dateModified":"2024-09-04T17:21:29+00:00","description":"Unlock the potential of aptamers & revolutionize your diagnostic device development! Discover the Aptamer Advantage.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/02\/The-Aptamer-Advantage-1.jpg","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2021\/02\/The-Aptamer-Advantage-1.jpg","width":930,"height":630,"caption":"The Aptamer Advantage: Breaking Free From Antibody Uncertainty"},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/the-aptamer-advantage-breaking-free-from-antibody-uncertainty\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"The Aptamer Advantage: Breaking Free from Antibody Uncertainty"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/34934951075d3d931c9216ed7f568fe6","name":"partyinfrance","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/92a1a8baadc8edb75908400eb770e42f1cacc51799ca019260cdbb36ac3ab4f1?s=96&d=mm&r=g","caption":"partyinfrance"}}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/1141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/comments?post=1141"}],"version-history":[{"count":23,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/1141\/revisions"}],"predecessor-version":[{"id":6082,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/posts\/1141\/revisions\/6082"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media\/6085"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/media?parent=1141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/categories?post=1141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/es\/wp-json\/wp\/v2\/tags?post=1141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}